Yoav Golan to Keynote at Anti-Infectives Meeting, July 10-11, 2014 in Boston, MA

Yoav Golan, Tufts Univ to Keynote at Anti-Infectives Conference on July 10-11, 2014, in Boston, MA. End Quote

(1888PressRelease) June 17, 2014 - Yoav Golan, Attending Physician; Associate Professor of Medicine, Tufts University School of Medicine to deliver a Keynote Presentation at the 11th Anti-Infectives Partnering and Deal-Making Conference on July 10-11, 2014, in Boston, MA, by GTCbio.

GTCbio's Anti-Infectives Partnering & Deal Making is an infectious disease partnering and business development conference that gives global biotechnology and pharmaceutical companies an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, explore potential collaborations, and learn about relevant anti-infective issues and deals that will affect the industry. This event also provides a unique venue for attendees to learn about the anti-infective business development trends, the infectious disease markets, and novel technologies that shape up the industry.

The conference will discuss antibiotic valuation and reimbursements, pricing strategies, current trends and recent deals, investment and seed stage funding opportunities, government collaborations, non-dilutive funding, evolution of the regulatory framework and pathways for limited use. Participants include Yoav Golan, Tufts University School of Medicine; Katherine Laessig, FDA; Michael N. Dudley, Rempex Pharmaceuticals/ The Medicines Company; Michael Eichberg, Achaogen; Barry Eisenstein, Cubist Pharmaceuticals; Mark Goldberger, Abbvie; Peter Hammann, Sanofi-Aventis Deutschland GmbH; Elizabeth Jungman, The Pew Charitable Trusts; Joseph Larsen, BARDA; Kevin Outterson, Boston University; Alex White, Roche; Barrett Thornhill, Antimicrobial Innovation Alliance; Benjamin Thorner, Merck Research Laboratories and many more!

This conference is also part of the Infectious Diseases World Summit 2014, which consists of this conference and two other conferences:

1) 12th Vaccines Research & Development: All Things Considered Conference
2) 3rd Annual Influenza Research and Development Conference

For more information, please visit www.gtcbio.com.

###

space

Other Related Press Releases